Promoting access to cancer medicines in Mexico: Seguro popular key policy components

Daniela Moye-Holz*, Anahí Dreser, Octavio Gómez-Dantés, Veronika J. Wirtz

*Corresponding author for this work

    Research output: Chapter in Book/Report/Conference proceedingChapterAcademicpeer-review

    1 Citation (Scopus)
    16 Downloads (Pure)

    Abstract

    In Mexico, Seguro Popular (SP) was created to reach universal health coverage, including cancer care, through the Fund for Protection Against Catastrophic Expenditure (FPGC). This chapter describes how SP addressed the components of the WHO Access to Medicines Framework on access to cancer medicines. 

    SP’s reimburserment guidelines cover medicines for basic cancer care and define reference prices, which are similar to international reference prices. Eight percent of SP’s resources are allocated to FPGC, of which 28% finance cancer care. Only accredited health facilities are reimbursed by SP, but their number is insufficient to satisfy demand. Different procurement mechanisms affect the availability of cancer medicines.

    Original languageEnglish
    Title of host publicationGlobal Pharmaceutical Policy
    PublisherPalgrave MacMillan
    Chapter7
    Pages177-222
    Number of pages46
    Edition1
    ISBN (Electronic)9789811527241
    ISBN (Print)9789811527234
    DOIs
    Publication statusPublished - 15-Jun-2020

    Keywords

    • Access
    • Cancer medicines
    • Financing
    • Mexico
    • Pricing
    • Procurement and supply
    • Selection
    • WHO access to medicines framework

    Fingerprint

    Dive into the research topics of 'Promoting access to cancer medicines in Mexico: Seguro popular key policy components'. Together they form a unique fingerprint.

    Cite this